Delivery Order SPE2DB22D1052-SPE2DB25FU8SB

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, with a Ceiling Value of $27,519.49. The contract has an Ultimate Completion Date of November 28, 2023 and a Firm Fixed Price pricing type. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ONDANSETRON ODT 8 MG TABLET 30S. The contract has a firm fixed price of $4,721.53 and a performance period ending on January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563118878 ONDANSETRON ODT 8 MG TABLET 30S. The contract is a Firm Fixed Price agreement with a ceiling value of $2,946.30 and an ultimate completion date of December 18, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,083.80, is for the delivery of 4566326369 ONDANSETRON ODT 4 MG TABLET 30S, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of November 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565220909 ! ONDANSETRON ODT 4 MG TABLET 30S, with a ceiling value of $3,734.62 and a completion date of July 23, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4563982731 - ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $13,057.29 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp has an existing indefinite delivery contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $13,746.27 and covers the delivery of ONDANSETRON ODT 4 MG TABLET 30S, a medical supply item, with a period of performance through April 25, 2024. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4566877513 ONDANSETRON ODT 8 MG TABLET 30S. The contract has a ceiling value of $5,941.43 and runs through January 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and this award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566809815 ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $8,133.74. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) that runs through December 31, 2024. AmerisourceBergen has a significant IDC with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,690.81, is for the delivery of 4567442957 ONDANSETRON ODT 4 MG TABLET 30S, with a completion date of March 4, 2025. The contract is a Firm Fixed Price type, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D1052
    Indefinite Delivery Contract
  • SPE2DB22D1052-SPE2DB25FU8SB
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $3,907.34 and a period of performance running through March 10, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/6/25, 9:57 AM